glp-1 discontinuation weight regain after cessation of medication for weight management: systematic review and meta-analysis what happens if you stop
Description
Zepbound is contraindicated in patients with a family history of medullary thyroid cancer (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Diabetic patients may access it via the Long-Term Illness (LTI) scheme
The vitamin and nutrient guide for GLP-1 users covers all the micronutrients worth monitoring
Protein intake matters because GLP-1 medications suppress appetite so effectively that many people accidentally eat 40% or more less protein, which speeds up muscle loss
